AbolerIS Pharma
AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases.
BioWin members represent a wide range of biopharma and health-tech organisations including research labs, big pharma, SMEs, universities, hospitals and training centres operating across Wallonia.
AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases.
Actemium Belgium has developed an established reputation in advice, study, realization and support for industrial processes in electricity, instrumentation, automation and assembly.
Ad Hoc Clinical is a privately owned CRO rendering services to all actors involved in clinical research (CRO’s, pharmaceutical industry, biotech, medical device companies...)
Leader in biotechnology for sustainable agriculture.
Amyl Therapeutics is developing a breakthrough platform of fusion proteins for the treatment of amyloid mediated diseases, including Alzheimer’s disease and Parkinson’s disease.
Anacura is the independent analytical centre of excellence in both healthcare and drug development.
Aquilon Pharma aims to play a disruptive role in the next generation formulation technology for inhaled medication by improving the efficacy of inhaled drug.
Aseptic Technologies improves the quality of aseptic operations by providing innovative and user-oriented state-of-the-art equipment, devices, and services to the pharmaceutical industry.
The reference in manufacturing for Biopharma, biotech and high-purity sites.
BECARV is an expert in the analysis, customization, integration and automation of end-to-end cell culture processes.
BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.
BioSourcing is developing a new generation of biotherapeutics, in particular monoclonal antibodies for global unmet medical needs : available, affordable, sustainable.
Bioxodes is a clinical stage company developing a first-in-class drug candidate, Ir-CPI, for the prevention of thrombosis and neuroinflammation in haemorrhagic stroke patients.
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products.
Celyad is specialised in CAR-T cell therapy and is developing landmark technologies aimed at treating severe diseases with poor prognosis such as cancer.
Cenexi is a global provider of contract development and manufacturing services.
CER Groupe is a Certified Research Center which provides services, analyses and products in medical, veterinarian, biotechnological, biomedical and agro-food fields.
Certech is a research & development partner and supplier of analytical and technological services for companies involved in activities related to (bio)chemistry.
Comunicare is specialised in e-health. The company develops and commercialises a digital solution to support patients in chronic care and post-hospitalization contexts.
ConvEyXO is a pioneering therapeutic company dedicated to unlocking the transformative power of exosomes.
companies
universities
hospitals
research centers